Skip to main content

Table 2 One-way and full sensitivity analyses performed as part of the cost-effectiveness evaluation

From: Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer

Component

Base case

Variation in sensitivity analysis

One-way sensitivity analysis

  

 Proportion of chronic dysphagia

50% chronic, 50% resolved within 5 years

Scenario 1: 0% chronic, 100% resolved within 5y

Scenario 2: 100% chronic, 0% resolved within 5y

 Cost of proton therapy (33 fx)

$36,659

Scenario 1: $31,659

Scenario 2: $26,659

Scenario 3: $21,659

Full sensitivity analysis

  

 QALY calculation

  

  Hazard ratio for patients with > 10   pack-year smoking history

1.73

Normal distribution matching 95% CI 1.17–2.57

  Quality-adjustment factors

 

Beta distributions matching 95% CIs:

  Dysphagia (grade ≥ 2)

0.83

0.70–0.93

  Esophagitis (grade ≥ 3)

0.66

0.35–0.90

  Xerostomia (grade ≥ 2)

0.82

0.72–0.90

  Hypothyroidism (elevated TSH with or without T4/T3 changes requiring hormone replacement)

0.97

0.94–0.98

  Oral mucositis (grade ≥ 3)

0.06

0.01–0.15

 Cost-effectiveness calculation

  

  Proportion of oral mucositis or esophagitis cases requiring inpatient hospital admission

10%

Normal distribution matching 95% CI 0–20%

  Proportion of oral mucositis cases resulting in emergency room visit

15%

Normal distribution matching 95% CI 5–25%

  Proportion of esophagitis cases resulting in emergency room visit

10%

Normal distribution matching 95% CI 0–20%

  Proportion of dysphagia cases requiring chronic PEG tube

10%

Normal distribution matching 95% CI 0–20%

  Proportion of patients receiving stricture dilation for dysphagia

16%

Normal distribution matching 95% CI 11–21%

  Cost of stricture dilation

$1700

Normal distribution matching 95% CI $1200–$2200

  1. More information about the components used in the quality-adjusted life years calculation can be found in ref [12]